|
J Biol Chem, Vol. 274, Issue 35, 24593-24601, August 27, 1999
Characterization of the Carboxyl-terminal Domain of the Rat
Glucose-dependent Insulinotropic Polypeptide (GIP)
Receptor
A ROLE FOR SERINES 426 AND 427 IN REGULATING THE RATE OF
INTERNALIZATION
Michael B.
Wheeler ,
Richard W.
Gelling§,
Simon A.
Hinke§,
Ba
Tu ,
Raymond A.
Pederson§,
Francis
Lynn§,
Jan
Ehses§, and
Christopher H. S.
McIntosh§
From the Departments of Medicine and Physiology,
University of Toronto, Toronto, Ontario M5S 1A8, Canada and the
§ Department of Physiology, University of British Columbia,
Vancouver V6T 1Z3, British Columbia, Canada
Glucose-dependent insulinotropic
polypeptide (GIP) is a gastrointestinal hormone involved in the
regulation of insulin secretion. In non-insulin-dependent
diabetes mellitus insulin responses to GIP are blunted, possibly due to
altered signal transduction or reduced receptor number. Site-directed
mutagenesis was used to construct truncated GIP receptors to study the
importance of the carboxyl-terminal tail (CT) in binding, signaling,
and receptor internalization. Receptors truncated at amino acids 425, 418, and 405, expressed in COS-7 or CHO-K1 cells, exhibited similar binding to wild type receptors. GIP-dependent cAMP
production with the 405 mutant was decreased in COS-7 cells. Maximal
cAMP production in CHO-K1 cells was reduced with all truncated forms. Binding was undetectable with a receptor truncated at amino acid 400;
increasing tail length by adding 5 alanines restored binding and
signaling. Mutants produced by alanine scanning of residues 394-401,
adjacent to transmembrane domain 7, were all functional. CT truncation
by 30 or more amino acids, mutation of serines 426/427, singly or
combined, or complete CT serine knockout all reduced receptor
internalization rate. The majority of the GIP receptor CT is therefore
not required for signaling, a minimum chain length of ~405 amino
acids is needed for receptor expression, and serines 426 and 427 are
important for regulating rate of receptor internalization.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Kim and J. M. Egan
The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
Pharmacol. Rev.,
December 1, 2008;
60(4):
470 - 512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Parthier, M. Kleinschmidt, P. Neumann, R. Rudolph, S. Manhart, D. Schlenzig, J. Fanghanel, J.-U. Rahfeld, H.-U. Demuth, and M. T. Stubbs
Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor
PNAS,
August 28, 2007;
104(35):
13942 - 13947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Deacon, A. Plamboeck, M. M. Rosenkilde, J. de Heer, and J. J. Holst
GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations
Am J Physiol Endocrinol Metab,
September 1, 2006;
291(3):
E468 - E475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Estall, J. A. Koehler, B. Yusta, and D. J. Drucker
The Glucagon-like Peptide-2 Receptor C Terminus Modulates {beta}-Arrestin-2 Association but Is Dispensable for Ligand-induced Desensitization, Endocytosis, and G-protein-dependent Effector Activation
J. Biol. Chem.,
June 10, 2005;
280(23):
22124 - 22134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Hinke, K. Hellemans, and F. C. Schuit
Plasticity of the {beta} cell insulin secretory competence: preparing the pancreatic {beta} cell for the next meal
J. Physiol.,
July 15, 2004;
558(2):
369 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Marie, C. Rouyer-Fessard, A. Couvineau, P. Nicole, H. Devaud, J. E. Benna, and M. Laburthe
Serine 447 in the Carboxyl Tail of Human VPAC1 Receptor Is Crucial for Agonist-Induced Desensitization but Not Internalization of the Receptor
Mol. Pharmacol.,
December 1, 2003;
64(6):
1565 - 1574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Pharmacol. Rev.,
March 1, 2003;
55(1):
167 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Hinke, R. W. Gelling, R. A. Pederson, S. Manhart, C. Nian, H.-U. Demuth, and C. H.S. McIntosh
Dipeptidyl Peptidase IV-Resistant [D-Ala2]Glucose-Dependent Insulinotropic Polypeptide (GIP) Improves Glucose Tolerance in Normal and Obese Diabetic Rats
Diabetes,
March 1, 2002;
51(3):
652 - 661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Horikawa, B. D. Gaylinn, C. E. Lyons Jr., and M. O. Thorner
Molecular Cloning of Ovine and Bovine Growth Hormone-Releasing Hormone Receptors: The Ovine Receptor Is C-Terminally Truncated
Endocrinology,
June 1, 2001;
142(6):
2660 - 2668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. C. Lynn, N. Pamir, E. H.C. Ng, C. H.S. McIntosh, T. J. Kieffer, and R. A. Pederson
Defective Glucose-Dependent Insulinotropic Polypeptide Receptor Expression in Diabetic Fatty Zucker Rats
Diabetes,
May 1, 2001;
50(5):
1004 - 1011.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|